Concepedia

Sherly Mardiana

SM

Statistics

Publications

10

Citations

1.9K

H-Index

10

Active since

2016

Affiliations

Peter MacCallum Cancer Centre(Current)

Monash University

The University of Melbourne

The Kids Research Institute Australia

The University of Western Australia

Sherly Mardiana is an author at Peter MacCallum Cancer Centre specializing in immunology, oncology, and cancer immunology.

ORCID

Publications per year

2016–2025

10

Publications

10

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade

Imran G. House, Peter Savas, Junyun Lai et al. · Clinical Cancer Research · 2019 · 766 citations

, , +17

Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy

Paul A. Beavis, Melissa A. Henderson, Lauren Giuffrida et al. · Journal of Clinical Investigation · 2017 · 321 citations · Full text

, , +17

Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity

Junyun Lai, Sherly Mardiana, Imran G. House et al. · Nature Immunology · 2020 · 215 citations

, , +17

CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy

Lauren Giuffrida, Kevin Sek, Melissa A. Henderson et al. · Nature Communications · 2021 · 210 citations · Full text

, , +17

Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting

Clare Y. Slaney, Bianca von Scheidt, Alexander J. Davenport et al. · Clinical Cancer Research · 2016 · 123 citations · Full text

, , +17

1–5 of 10